Register entry
FAMYGEN LIFE SCIENCES INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 11
- Countries
- 0
Exclusivity
Patents and exclusivities
11| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10278918 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 10772829 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 11090261 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 11844858 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 12350366 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 9795560 | RYZUMVIphentolamine mesylate | product | Jan 2034 |
| 11400077 | RYZUMVIphentolamine mesylate | use | Oct 2039 |
| 12201615 | RYZUMVIphentolamine mesylate | use | Oct 2039 |
| 12201616 | RYZUMVIphentolamine mesylate | use | Oct 2039 |
| 12576066 | RYZUMVIphentolamine mesylate | use | Oct 2039 |
| 12576067 | RYZUMVIphentolamine mesylate | use | Oct 2039 |
Enquiry
Common questions
- Is FAMYGEN LIFE SCIENCES INC FDA approved?
- FAMYGEN LIFE SCIENCES INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.